Article info
ORIGINAL ARTICLE
Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients
- Address correspondence and reprint requests to: Prof. Ignace Vergote, MD, PhD, Division of Gynecologic Oncology, Department of Gynecologic Oncology, University Hospitals Leuven, Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. Email: ignace.vergote{at}uz.kuleuven.ac.be
Citation
Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients
Publication history
- First published January 1, 2006.
Online issue publication
January 01, 2006
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2006 Blackwell Publishing Ltd.